Medindia

X

Cardiac Science Adds NextGen to Its Roster of Certified EMR System Partners

Tuesday, April 1, 2008 General News J E 4
Advertisement
BOTHELL, Wash., March 31 Cardiac ScienceCorporation (Nasdaq: CSCX), a global leader in advanced cardiac diagnosis,resuscitation, rehabilitation, and informatics products, announced today atthe 2008 American College of Cardiology conference that it completedcertification for its HeartCentrix(R) ECG informatics software with NextGenHealthcare Information Systems. NextGen is a leading developer and provider ofcomputer-based practice management and electronic medical record (EMR) systemsfor medical group practices and healthcare systems.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080306/AQTH510LOGO)

Featuring the industry's most robust cardiology knowledgebase, the NextGenEMR system is used by more than 1,500 clients nationwide -- including manyleading cardiology practices. These current clients, as well as futureclients, will be readily able to take advantage of connectivity to theHeartCentrix(R) informatics software. In addition, the integration will beleveraged through the tens of thousands in Cardiac Science's installed base ofcustomers.

Designed to integrate seamlessly EMR and other information systems,HeartCentrix solutions help streamline workflow in multiple health careenvironments. HeartCentrix -- which enables seamless data transfer fromBurdick(R) and Quinton(R) electrocardiograph (ECG) devices, cardiac stress,and Holter monitoring devices to physician EMR software -- can be installedwith a new NextGen EMR implementation, or just as easily into an existingNextGen account.

Tony Titus, Cardiac Science vice president of marketing, reported thatHeartCentrix and NextGen recently began deployment for their first jointinstallation, a multi-site cardiology practice of more than 60 physicians."Pairing HeartCentrix with NextGen connects diagnostic devices and EMR systemstogether for office-wide efficiencies, and a greater ROI on the EMRinvestment," he said.

"HeartCentrix is a great solution for our clients who rely on Burdick andQuinton diagnostic devices in particular," said Debra Dore, director ofcardiology products for NextGen. "Bringing information from HeartCentrix intothe NextGen EMR platform will enable a smoother office workflow, fasterdiagnosis and therapeutic decision-making and, ultimately, better patientcare."

About NextGen

NextGen Healthcare Information Systems, Inc. a wholly owned subsidiary ofQuality Systems, Inc. (Nasdaq: QSII), develops and markets computer-basedpractice management and electronic medical records systems for medical grouppractices and healthcare systems. For more information about NextGen, pleasevisit http://www.nextgen.com and http://www.qsii.com.

About Cardiac Science

Cardiac Science develops, manufactures, and markets a family of advanceddiagnostic and therapeutic cardiology devices and systems, including automatedexternal defibrillators (AEDs), electrocardiograph devices (ECGs), cardiacstress systems and treadmills, Holter monitoring systems, hospitaldefibrillators, cardiac rehabilitation telemetry systems, and cardiology datamanagement systems (informatics) that connect with hospital information (HIS),electronic medical record (EMR), and other information systems. The Companysells a variety of related products and consumables, and provides a portfolioof training, maintenance, and support services. Cardiac Science, the successorto the cardiac businesses that established the trusted Burdick(R),HeartCentrix(R), Powerheart(R), and Quinton(R) brands, is headquartered inBothell, Washington. With customers in more than 100 countries worldwide, thecompany has operations in North America, Europe, and Asia. For information,call 425.402.2000 or visit http://www.cardiacscience.com.

Forward Looking Statements

This press release contains forward-looking statements. These statementsand their underlying assumptions involve a number of risks and uncert
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Medco Partners to Develop Patient-Safety System fo...
S
The United States Patent and Trademark Office Gran...